Copyright: ©Author(s) 2026.
World J Exp Med. Jun 20, 2026; 16(2): 118228
Published online Jun 20, 2026. doi: 10.5493/wjem.v16.i2.118228
Published online Jun 20, 2026. doi: 10.5493/wjem.v16.i2.118228
Table 1 Circadian disruption and social jet lag as modifiers of associated steatotic liver disease pathogenesis and management
| Domain | Circadian/SJL-related factor | MASLD-relevant mechanism | Ref. |
| Disease framework | Circadian regulation of metabolic homeostasis | Hepatic lipid handling, glucose metabolism, and inflammatory pathways are under circadian control; disruption amplifies insulin resistance and steatosis | [15,16] |
| Lifestyle modifiers | SJL | Persistent misalignment between endogenous clocks and behavioural schedules promotes metabolic inflammation independent of caloric excess | [5,7] |
| Gut-liver axis | Rhythmic intestinal barrier function | Tight junction proteins (occludin, claudin-1) show circadian oscillation; disruption increases permeability and endotoxin flux | [6,8] |
| Innate immunity | Circadian gating of immune responses | Toll-like receptor signalling varies by time of day; circadian disruption exaggerates inflammatory responses to microbial products | [10] |
| Gut microbiota | Temporal dysbiosis | Circadian disruption blunts microbial diurnal oscillations, impairing host–microbe metabolic signalling | [5,12] |
| Metabolite signalling | SCFAs as clock synchronisers | SCFAs (e.g., butyrate) entrain epithelial and hepatic clocks via HDAC inhibition; arrhythmic delivery weakens metabolic homeostasis | [11,13] |
| Bile acid metabolism | Circadian bile acid-FXR axis | Diurnal bile acid oscillations regulate hepatic lipid and glucose metabolism; disruption impairs FXR signalling | [14,18] |
| Human phenotype | Nocturnal metabolic vulnerability | MASLD associated with exaggerated nocturnal insulin resistance and reduced nighttime insulin availability | [15] |
| Dietary intervention | Time-restricted eating | Consistent eating windows restore hepatic and microbial rhythmicity, improving insulin sensitivity and reducing liver fat | [21,29] |
| Microbiota-targeted therapy | Circadian dependence of efficacy | FMT efficacy correlates with restoration of microbial rhythmicity | [23,29] |
| Adjunctive strategies | Chronobiotics (e.g., melatonin) | Chronobiotics can re-entrain host–microbial rhythms under circadian disruption | [22] |
| Research considerations | Timing as a biological confounder | Ignoring circadian timing may obscure biomarker interpretation and treatment effects | [5] |
- Citation: Savvidis C, Ilias I. Letter to the Editor: Circadian and microbial misalignment in metabolic dysfunction-associated steatotic liver disease - mechanistic insights and chronotherapeutic potential. World J Exp Med 2026; 16(2): 118228
- URL: https://www.wjgnet.com/2220-315x/full/v16/i2/118228.htm
- DOI: https://dx.doi.org/10.5493/wjem.v16.i2.118228